Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2024 Mar 5;14:5424. doi: 10.1038/s41598-024-54563-2

Projection of diabetes morbidity and mortality till 2045 in Indonesia based on risk factors and NCD prevention and control programs

Mugi Wahidin 1,2,3, Anhari Achadi 4,, Besral Besral 4, Soewarta Kosen 5, Mardiati Nadjib 4, Atik Nurwahyuni 4, Sudarto Ronoatmodjo 4, Ekowati Rahajeng 2, Masdalina Pane 2, Dian Kusuma 6
PMCID: PMC10914682  PMID: 38443384

Abstract

Diabetes Mellitus is one of the biggest health problems in Indonesia but the research on the disease’s projection is still limited. This study aimed to make a projection model of prevalence and mortality of diabetes in Indonesia based on risk factors and NCD programs. The study was a quantitative non-experimental study through multiple linear regression models and system dynamics. The baseline projection was created by 2018 data and projections until 2045 involved the dynamization of risk factors and programs, population, and case fatality rate. The model was created from 205 districts data. This study used secondary data from Basic Health Research, BPJS Kesehatan, NCD programs, and Ministry of Health. The prevalence of diabetes in Indonesia is estimated to increase from 9.19% in 2020 (18.69 million cases) to 16.09% in 2045 (40.7 million cases). The prevalence will be lower to 15.68% (39.6 million) if interventions of programs were carried out, and to 9.22% (23.2 million) if the programs were added with prevention of risk factors. The projected number of deaths due to diabetes increases from 433,752 in 2020 to 944,468 in 2045. Deaths due to stroke among diabetes increases from 52,397 to 114,092 in the same period. Deaths from IHD among diabetes increase from 35,351 to 76,974, and deaths from chronic kidney disease among diabetes increase from 29,061 to 63,279. Diabetes prevalence and mortality in Indonesia rise significantly in Indonesia and can be reduced by intervention of several programs and risk factors. This study findings could be source of planning and evaluation of Diabetes prevention and control program at national and provincial level in the future related to risk factors control and program development.

Keywords: Diabetes, Projection, Prevalence, Mortality

Subject terms: Diseases, Endocrinology, Health care, Medical research, Risk factors

Introduction

The burden of Diabetes, one of main Non-Communicable Diseases (NCD), in term of prevalence and mortality becomes a serious problem in the word as well as in Indonesia. The prevalence rate of the disease was 5943 per 100.000 population in 2019 worldwide, which rose from 2968 per 100,000 in 1990. Meanwhile, the mortality rate was 20.5 per 100,000 population which increased from 12.37 per 100,000 in 19901. In Indonesia, the prevalence was 5.7% among adults in 2007 became 6.9% in 2013 and 8.5% in 201824.

There was common risk factors related to Diabetes such as obesity, smoking, unhealthy diet, lack of physical activity, hypertension, raised in blood glucose, and increase of cholesterol57. Similarly, study of Peters et al.8 revealed that unhealthy diet, lack of physical activity, smoking, hypertension, and obesity. The study of Kristianita described that there was a significant relationship between fruit and vegetable consumption, physical activity, and the incidence of type 2 Diabetes. Moreover, the study of Zhang et al.9 stated that overweight, obesity, high triglyceride, and hypertension are risk factors for Diabetes in men and women.

Diabetes becomes part of main disease prevention and control program in Indonesia that is included in the National Medium-Term Development Plan 2020–202410, Strategic Plan of the Ministry of Health 2020–202411, and indicators in the Minimum Service Standards for district government12. Thus, there are several NCD programs developed nationally namely NCD integrated post (Posbindu), NCD integrated Service in Primary Health Center (Pandu), as well as the Chronic Disease Service (Prolanis) program7. Furthermore, there are also screening program including obesity, central obesity, and program of Diabetes standard services in the minimum service standards (SPM) as obligation of district government12. The program might influence the development of diabetes, but information of the influence was still limited.

In order to develop adequate prevention and control programs of diabetes, projection of the diseases, especially morbidity and mortality is needed. Projection of Diabetes prevalence may be developed using risk factors and prevention and control programs. The research of Meng et al.13 included risk factors used for diabetes projection, namely body mass index, smoking, alcohol consumption, physical activity, and meat, fish, and vegetable consumption. Meanwhile, the research of Nai-Arun and Moungmai, used smoking, alcohol consumption, family history of diabetes, family history of hypertension, weight, BMI, blood pressure, age, and sex as predictors of14.

Projection of the prevalence and mortality of diabetes mellitus is still limited in Indonesia. One of the Diabetes burden study in Indonesia was conducted in 1993, which showed that the Diabetes treatment burden in Indonesia reached IDR 1.5 billion per day or IDR 500 billion a year15. Another study was a projection till 2024 by Nurhayati16 that by 2020 the prevalence of Diabetes in Indonesia was 8.71% which rose from 8.13% in 2017 and becomes 9.49% in 2024. This study was a literature review based on Institute of Health Metric and Evaluation (IHME) data. Compared to the existing data, the prevalence of 2017 was lower than 2018 national data (8.5%)4.

Diabetes burden projection research has been conducted in various countries. Research by Tan et al.17 in Singapore on the projection of Diabetes complications in 2050 in the form of acute myocardial infarction is estimated to increase from 9300 in 2019 to 16,400 in 2050. The number of strokes increased from 7300 to 12,800, and the number of end-stage kidney disease from 1700 to 270017. Research by Rowley, et al. (2017) on Diabetes projections in the United States through 2030 shows that Diabetes prevalence increases by 54% or more than 54.9 million population between 2015 and 2030, with Diabetes—related deaths increasing 38% to 385,800 people per year18. Another Diabetes projection study by Boyle et al.19 in the United States shows that the incidence of DM is expected to increase from 8 cases per 1000 in 2008 to 15 by 2050.

Besides influence of the risk factors, influence of prevention and control program to diabetes is not known clearly. The projection is needed to estimate the burden and develop anticipated prevention and control program. The previous projection of diabetes in Indonesia used regression based on risk relative of the risk factors only. Thus, we conducted the study to develop projection of diabetes prevalence and mortality based on risk factors and NCD prevention and control programs in Indonesia. The projection of diabetes using modeling of risk factors and NCD control programs in this manuscript is the first method in Indonesia.

Methods

Study design

The study used a quantitative non-experimental study design through developing projection models with multiple linear regression and system dynamics. The model was based on risk factors and Diabetes prevention and control programs, as well as population size, Diabetes risk factor growth, Diabetes prevention and control program growth, case fatality rate, and population projection. This study used secondary data from Basic Health Research 2007, 2013, 2018, National Health Insurance Body (BPJS) 2016–2020, Directorate of P2PTM Ministry of Health 2016–2020, Center for Data and Information the Ministry of Health (2019–2021), and the Central Bureau of Statistics. Wes use district level as analysis unit. This study used risk factors and program of Diabetes to project the morbidity and mortality of Diabetes which was a new method of analysis in projection of the disease in Indonesia. The previous study in Indonesia used only risk factors and existing cases to project the disease.

Study approval

The study was approved by Universitas Indonesia and the authors confirmed that all methods were performed in accordance with the relevant guidelines and regulations in Universitas Indonesia.

Dependent variable

The dependent variables were diabetes morbidity and mortality. Morbidity means prevalence of diabetes, which was defined as percentage of adult respondent (15 years and above) who had diabetes based on medical doctor diagnosis which was adjusted by the prevalence of diabetes based on blood glucose measurement (8.5%). The mortality was number of deaths due to diabetes, number of death due to stroke among diabetes cases, deaths due to ischemic health disease among diabetes cases, and deaths due to chronic kidney disease among diabetes cases.

Independent variables

There were 10 risk factors and 8 NCD prevention and control programs included in the projection model. The risk factors consisted of prevalence of overweight, obesity, central obesity, sweet food consumption, sugary beverage consumption, fatty food consumption, lack of fruit and vegetable consumption, lack of physical activity, smoking, and hypertension. Meanwhile, the prevention and control programs included Posbindu, village running Posbindu, examination of Posbindu, Pandu, Prolanis, routine checking blood glucose, Minimum standard service (SPM) for Diabetes services and minimum standard services of NCD screening.

Overweight was categorized by body mass index (BMI) for 25–26.9, meanwhile 27 and above for obesity. Central obesity category was waist circumferences 90 cm (males) and 80 and above (females). Sweety food consumption was consumption the food containing excessive sugar/carbohydrate 1 time or more a day and sweety beverage consumption was consumption the drinking water containing excessive sugar 1 time or more a day. Fatty food consumption was consumption excessive fat/fried food 1 or more a day. Lack of fruit and consumption was no consumption of or less than 5 portions of fruit or vegetables a day. Moreover, Lack of physical activity was less 30 min or 150 min moderate physical activity a day. Smoking meant active smoking in the last month. Meanwhile, hypertension was based on blood pressure examination for those who has systole of 140 mmHg or diastole for 90 mmHg.

Posbindu was a community participation on detecting and monitoring NCD risk factors. Village running Posbindu meant village that has active Posbindu. Examination of Posbindu was activity of NCD risk factors detection namely smoking, physical activity, fruit and vegetable consumption, weight and height measurement, blood pressure measurement, and blood measurement. Pandu was an activity of detection of NCD risk factors, detection of NCD cases and standard treatment in primary health centers. Prolanis is a chronic disease management, including diabetes and hypertension, run by primary health center with activities of monthly blood glucose measurement, blood pressure measurement, treatment, physical activity, and counseling.

Coverage of village running Posbindu was percentage of village had Posbindu, coverage of Posbindu examination was percentage of members examined in the Posbindu. Coverage of Pandu is percentage of Primary health center (PHC) developing integrated NCD, coverage of Prolanis was member of Prolanis among people aged 15 years and above. Routine of blood glucose checking was percentage of people who regularly checks blood glucose monthly. Coverage of SPM Diabetes service was percentage of Diabetes patients have standard treatment, and coverage of NCD screening was people aged 15 years and above who have complete screening for NCD risk factors.

Data analysis

Data analysis performed in the study was development of baseline prevalence and mortality projection in 2018 using multiple linear regression and projections till 2045 using system dynamics. Multiple Linear regression was developed through step of bivariate selection, multivariate modelling, and final model development20,21. Bivariate selection was performed by correlation analysis between risk factors and diagnosed Diabetes prevalence, which risk factors that had p value less than 0.25 was inputted into full model20. Based on bivariate analysis, 16 out of 18 predictors were included in the full model. Two risk factors namely sweety food consumption and sweety beverage consumption were excluded.

The multivariate testing used Enter method. Then, the multivariate modelling was performed by excluding variables from full model that had p value more than 0.05. If the variable did not influence R2 and B of other variables for 10%, the variables were kept excluded. The variables excluded from final model were Pandu and lack of fruit and vegetables consumption. So, there were 14 determinants included in the final model. In order to justify the fit of the model, all assumption of multiple linear regression were tested, for existence, independence, linearity, homoscedasticity, normality, and collinearity20,21 After testing, all assumption were complied.

Based on multiple linear regression analysis, there were 9 variables consisting of 4 risk factors and 5 prevention and control programs as predictors of Diabetes prevalence in the final model. With R2 0.571, the model described as Diabetes prevalence = − 1.212 + 0.216 overweight prevalence + 0.017 obesity prevalence + 0.112 central obesity prevalence + 0.019 prevalence of fatty food consumption–0.001 Percentage of villages with PTM Posbindu + 0.003 percentage of Pandu + 1.510 prevalence of routine blood sugar checks−0.012 SPM coverage of DM Diabetes service + 0.008 SPM coverage productive age screening.

In order to make a projection to 2045, we incorporate trend/dynamization of each risk factor and program. Risk factors’ trend based on their trends from 2007 to 2018 based on Basic Health research Data. Trend of the program based on data from 2016 to 2020. Assumption of SPM of Diabetes health services and SPM of productive age screening using random normal based on the average of 3 years (2019–2021) and its standard deviation.

Assumptions of case fatality rate of diabetes and proportion of its complication were based on BPJS data 2016–2020. Case fatality rate of Diabetes was 2.32% for diabetes, proportion of death due to stroke, ischemic heart disease, and chronic kidney disease among Diabetes cases was 12.08%, 8.15%, and 6.7% respectively. Meanwhile, assumption of neuropathy due to diabetes was 53.64%22, retinopathy was 30.7%23, and Diabetes Keto Acidosis (DKA) among diabetes cases was 3,07%24 and its mortality for 72 h was 28.57%25. Projection was made in three scenarios, namely scenario without intervention (scenario 1), scenario with program intervention of village with Posbindu and SPM of Diabetes services each 100% coverage (scenario 2), and scenario with program intervention and halt of the rate of risk factors (overweight, obesity, central obesity, and fatty food consumption) as condition in 2018. The projection results have been declared valid after discussion with experts and have an Absolute Mean Percentage Error (MAPE) of 12% for provincial and national projections and 23% for district/city projections26. For generating maps, Looker Studio software with release date on 20 December 2022 was used in this geographical distribution analysis using results of this study. The software could be accessed at https://lookerstudio.google.com/overview.

Ethics approval and consent to participate

The study was approved by The Research and Community Engagement Ethical Committee Faculty of Public Health Universitas Indonesia No. Ket-438/UN2.F10.D11/PPM.00.02/2022 on June 22nd 2022. The data (aggregate data) used in this study were anonymized before its use. Following The Guideline and Ethical Standard of National Health Research and Development issued by Ethical Board of National Health Research and Development, Ministry of Health (2013), this study did not use informed consent as it used secondary data. The authors had permission to use the data from each secondary data holder, namely Head of Policy and Development Body, Ministry of Health, Director of Non-Communicable Disease Prevention and Control, Ministry of Health, and Director of National Health Insurance (BPJS).

Consent for publication

We, the authors, give our consent for the publication of this paper, which can include detail of tables and figures to be published in Scientific Reports. Data of diabetes prevalence and ant the risk factors 2007 can be accessed at https://labmandat.litbang.kemkes.go.id/adownload/?id=2&lkey=82206a9b1521b38 (closed), 2013 at https://labmandat.litbang.kemkes.go.id/adownload/?id=3&lkey=4c9c023be7c4a12 (closed), and 2018 at https://labmandat.litbang.kemkes.go.id/adownload/?id=4&lkey=8ad2f351fd26042 (closed). Data of Indonesia population can be accessed at https://www.bps.go.id/subject/12/kependudukan.html#subjekViewTab5 (open). Links of diabetes risk factors were granted from Head of Policy and Development Body, Ministry of Health. Data of national NCD programs supplied by Director of Non-Communicable Disease Prevention and Control, Ministry of Health. Data of diabetes mortality was supplied by Director of National Health Insurance (BPJS).

Results

Projection of diabetes prevalence

The prevalence and number of Diabetes cases (total) in Indonesia and in each province is estimated to increase quite high in 2020–2045. Nationally, Diabetes prevalence increased from 9.19% in 2020 (18.69 million cases) to 16.09% in 2045 (40.7 million cases). It rose 75.1% over 25 years, with an average increase of 3% from prevalence per year. The provinces with the highest prevalence in 2045 are Jakarta (23.11%) and the lowest East Nusatenggara province (8.91%) (Fig. 1a, Table 1). Based on seven regions, Java-Bali region had the highest average of Diabetes prevalence (18.27%) and the lowest was Nusatenggara region (10.87%) (Fig. 1b). The most cases in 2045 are in West Java Province (7,170,569 cases) and the lowest in North Kalimantan Province (138,038 cases) (Fig. 1c, Table 2). The microvascular complication of diabetes, namely neuropathy and retinopathy were also projected to rise from 2020 to 2045. Neuropathy increased from 10,028,638 cases to 21,836,747 cases and retinopathy rose from 5,739,732 cases to 12,497,915. The highest cases of 2045 were in West Java province with 3,846,293 cases and 2,201,365 and the lowest was in North Kalimantan Province with 74,044 cases and 42,378 cases for neuropathy and retinopathy, respectively (Tables 3 and 4).

Figure 1.

Figure 1

Projection of Morbidity of Diabetes in Indonesia 2045.

Table 1.

Projection of DIABETES PREVALENCE IN Indonesia, 2020–2045, by province.

No Province Diabetes prevalence projection (%)
2020 2025 2030 2035 2040 2045
1 Aceh 8.31 9.87 11.45 13.14 14.74 16.39
2 North Sumatera 8.84 10.34 11.72 13.17 14.76 15.83
3 West Sumatera 8.42 9.99 11.53 13.35 14.94 16.55
4 Riau 8.58 10.40 12.26 14.08 15.81 17.70
5 Jambi 6.77 8.09 9.51 10.83 12.43 14.28
6 South Sumatera 7.35 9.15 11.01 12.90 14.92 16.83
7 Bengkulu 7.17 8.64 9.68 10.98 12.47 14.49
8 Lampung 6.63 8.10 9.61 11.05 12.64 13.86
9 Bangka Belitung Island 9.66 11.07 12.69 14.23 15.52 17.16
10 Riau Island 9.54 10.91 12.29 13.73 15.15 16.47
11 Jakarta 14.30 16.09 18.12 19.60 21.40 23.11
12 West Java 9.42 10.56 11.62 12.78 13.90 14.95
13 Central Java 8.99 10.44 11.73 13.23 14.50 15.86
14 Yogyakarta 12.60 14.31 16.08 17.84 19.99 21.94
15 East Java 10.07 11.55 12.86 14.08 15.51 17.01
16 Banten 9.66 10.58 12.22 13.18 14.43 15.56
17 Bali 10.31 12.25 13.93 15.87 17.31 19.43
18 West Nusa Tenggara 6.58 7.41 8.97 10.06 11.64 12.84
19 East Nusa Tenggara 3.89 5.10 6.10 6.90 8.09 8.91
20 West Kalimantan 7.28 8.76 9.76 11.39 13.16 14.48
21 Central Kalimantan 7.43 8.50 9.65 10.89 12.01 12.97
22 South Kalimantan 8.89 10.27 11.52 12.88 14.23 15.42
23 East Kalimantan 12.36 13.70 15.23 17.01 18.58 20.25
24 North Kalimantan 14.33 14.83 15.64 16.18 16.53 17.29
25 North Sulawesi 10.61 11.76 12.82 13.46 14.85 15.84
26 Central Sulawesi 9.12 10.30 10.99 12.18 13.31 14.72
27 South Sulawesi 8.62 10.64 12.25 14.37 16.07 17.99
28 Southeast Sulawesi 8.22 9.59 10.99 12.65 14.20 15.68
29 Gorontalo 10.62 12.26 12.85 14.57 15.88 17.03
30 West Sulawesi 7.47 9.41 11.24 13.27 15.25 17.13
31 Maluku 7.89 9.33 10.90 12.41 13.97 15.55
32 North Maluku 8.84 9.33 10.97 12.12 12.87 14.28
33 West Papua 8.89 9.83 10.99 12.30 12.98 14.28
34 Papua 7.71 8.37 9.08 9.97 10.87 11.19
Indonesia 9.19 10.61 11.89 13.37 14.79 16.09

Table 2.

Projection of diabetes cases in Indonesia, 2020–2045, by province.

No Province Number of diabetes cases projection
2020 2025 2030 2035 2040 2045
1 Aceh 321,498 416,124 519,639 635,349 751,360 873,750
2 North Sumatera 943,618 1,187,416 1,432,263 1,688,543 1,965,634 2,171,341
3 West Sumatera 337,347 430,949 532,139 652,695 765,778 881,138
4 Riau 422,944 577,337 749,983 930,448 1,115,769 1,323,481
5 Jambi 182,506 232,864 288,936 343,965 408,111 480,378
6 South Sumatera 462,350 617,245 789,789 977,323 1,181,214 1,379,270
7 Bengkulu 107,272 138,246 163,836 195,098 229,731 274,375
8 Lampung 423,440 549,083 684,452 817,592 960,440 1,072,210
9 Bangka Belitung 106,364 131,390 160,724 190,355 217,009 248,833
10 Riau Island 162,291 218,131 283,507 362,349 453,336 555,171
11 Jakarta 1,170,540 1,363,348 1,578,110 1,746,904 1,932,776 2,093,705
12 West Java 3,526,676 4,247,308 4,953,851 5,708,318 6,456,651 7,170,569
13 Central Java 2,425,092 2,935,055 3,397,962 3,902,698 4,320,404 4,745,282
14 Yogyakarta 393,501 476,903 568,148 667,693 791,184 916,821
15 East Java 3,184,025 3,768,696 4,285,593 4,769,819 5,287,282 5,784,386
16 Banten 928,816 1,107,764 1,375,654 1,578,329 1,816,134 2,039,772
17 Bali 355,352 454,496 547,063 655,054 745,547 868,706
18 West Nusa Tenggara 250,425 306,043 399,144 478,727 584,753 673,995
19 East Nusa Tenggara 150,977 213,758 274,306 331,772 411,342 474,199
20 West Kalimantan 275,238 356,041 421,828 517,757 623,131 707,526
21 Central Kalimantan 149,556 185,747 225,840 269,995 311,710 348,806
22 South Kalimantan 279,663 348,269 418,653 494,369 569,880 639,636
23 East Kalimantan 342,169 408,152 482,296 565,851 642,241 721,296
24 North Kalimantan 74,716 86,172 100,094 112,312 123,511 138,038
25 North Sulawesi 204,505 237,340 268,411 289,644 324,898 349,627
26 Central Sulawesi 206,043 250,766 286,394 336,462 386,178 445,155
27 South Sulawesi 580,477 753,698 906,079 1,098,762 1,257,503 1,430,337
28 Southeast Sulawesi 158,586 202,326 250,555 309,283 369,209 429,852
29 Gorontalo 94,747 115,651 126,838 148,940 166,522 181,961
30 West Sulawesi 73,876 101,234 130,401 164,058 198,693 232,765
31 Maluku 101,568 128,630 159,333 190,583 223,357 257,124
32 North Maluku 79,931 91,795 116,083 136,318 152,464 177,012
33 West Papua 62,882 79,741 100,719 125,626 146,392 176,556
34 Papua 190,147 224,240 260,512 302,616 344,685 367,506
Indonesia 18,696,194 22,990,010 27,138,625 31,855,207 36,449,447 40,709,820

Table 3.

Projection of neuropathy due to diabetes in Indonesia, 2020–2045, by province.

No Province Number of diabetes cases projection
2020 2025 2030 2035 2040 2045
1 Aceh 172,452 223,209 278,735 340,801 403,029 468,679
2 North Sumatera 506,157 636,930 768,266 905,735 1,054,366 1,164,707
3 West Sumatera 180,953 231,161 285,439 350,106 410,763 472,642
4 Riau 226,867 309,684 402,291 499,092 598,498 709,915
5 Jambi 97,896 124,908 154,985 184,503 218,911 257,675
6 South Sumatera 248,005 331,090 423,643 524,236 633,603 739,840
7 Bengkulu 57,541 74,155 87,882 104,651 123,227 147,175
8 Lampung 227,133 294,528 367,140 438,556 515,180 575,134
9 Bangka Belitung 57,054 70,478 86,212 102,106 116,404 133,474
10 Riau Island 87,053 117,005 152,073 194,364 243,170 297,794
11 Jakarta 627,877 731,300 846,498 937,039 1,036,741 1,123,063
12 West Java 1,891,709 2,278,256 2,657,246 3,061,942 3,463,348 3,846,293
13 Central Java 1,300,819 1,574,364 1,822,667 2,093,407 2,317,465 2,545,369
14 Yogyakarta 211,074 255,811 304,754 358,151 424,391 491,783
15 East Java 1,707,911 2,021,528 2,298,792 2,558,531 2,836,098 3,102,745
16 Banten 498,217 594,205 737,901 846,616 974,174 1,094,134
17 Bali 190,611 243,791 293,444 351,371 399,912 465,974
18 West Nusa Tenggara 134,328 164,161 214,101 256,789 313,662 361,531
19 East Nusa Tenggara 80,984 114,660 147,138 177,963 220,644 254,360
20 West Kalimantan 147,637 190,980 226,268 277,725 334,247 379,517
21 Central Kalimantan 80,222 99,635 121,140 144,825 167,201 187,099
22 South Kalimantan 150,011 186,811 224,565 265,180 305,684 343,101
23 East Kalimantan 183,540 218,933 258,704 303,522 344,498 386,903
24 North Kalimantan 40,077 46,223 53,690 60,244 66,251 74,044
25 North Sulawesi 109,696 127,309 143,976 155,365 174,275 187,540
26 Central Sulawesi 110,522 134,511 153,622 180,478 207,146 238,781
27 South Sulawesi 311,368 404,283 486,021 589,376 674,525 767,233
28 Southeast Sulawesi 85,066 108,528 134,398 165,900 198,044 230,572
29 Gorontalo 50,822 62,035 68,036 79,891 89,322 97,604
30 West Sulawesi 39,627 54,302 69,947 88,001 106,579 124,855
31 Maluku 54,481 68,997 85,466 102,228 119,809 137,921
32 North Maluku 42,875 49,239 62,267 73,121 81,782 94,949
33 West Papua 33,730 42,773 54,026 67,386 78,525 94,705
34 Papua 101,995 120,282 139,738 162,323 184,889 197,130
Indonesia 10,028,638 12,331,842 14,557,158 17,087,133 19,551,483 21,836,747

Table 4.

Projection of retinopathy due to diabetes in Indonesia, 2020–2045, by province.

No Province Number of diabetes cases projection
2020 2025 2030 2035 2040 2045
1 Aceh 98,700 127,750 159,529 195,052 230,667 268,241
2 North Sumatera 289,691 364,537 439,705 518,383 603,450 666,602
3 West Sumatera 103,566 132,301 163,367 200,377 235,094 270,509
4 Riau 129,844 177,243 230,245 285,648 342,541 406,309
5 Jambi 56,029 71,489 88,703 105,597 125,290 147,476
6 South Sumatera 141,942 189,494 242,465 300,038 362,633 423,436
7 Bengkulu 32,932 42,442 50,298 59,895 70,527 84,233
8 Lampung 129,996 168,569 210,127 251,001 294,855 329,169
9 Bangka Belitung 32,654 40,337 49,342 58,439 66,622 76,392
10 Riau Island 49,823 66,966 87,037 111,241 139,174 170,437
11 Jakarta 359,356 418,548 484,480 536,299 593,362 642,767
12 West Java 1,082,690 1,303,923 1,520,832 1,752,454 1,982,192 2,201,365
13 Central Java 744,503 901,062 1,043,174 1,198,128 1,326,364 1,456,802
14 Yogyakarta 120,805 146,409 174,421 204,982 242,893 281,464
15 East Java 977,496 1,156,990 1,315,677 1,464,335 1,623,196 1,775,807
16 Banten 285,147 340,084 422,326 484,547 557,553 626,210
17 Bali 109,093 139,530 167,948 201,101 228,883 266,693
18 West Nusa Tenggara 76,880 93,955 122,537 146,969 179,519 206,916
19 East Nusa Tenggara 46,350 65,624 84,212 101,854 126,282 145,579
20 West Kalimantan 84,498 109,304 129,501 158,951 191,301 217,210
21 Central Kalimantan 45,914 57,024 69,333 82,888 95,695 107,083
22 South Kalimantan 85,856 106,919 128,526 151,771 174,953 196,368
23 East Kalimantan 105,046 125,303 148,065 173,716 197,168 221,438
24 North Kalimantan 22,938 26,455 30,729 34,480 37,918 42,378
25 North Sulawesi 62,783 72,863 82,402 88,921 99,744 107,335
26 Central Sulawesi 63,255 76,985 87,923 103,294 118,557 136,663
27 South Sulawesi 178,206 231,385 278,166 337,320 386,054 439,113
28 Southeast Sulawesi 48,686 62,114 76,920 94,950 113,347 131,964
29 Gorontalo 29,087 35,505 38,939 45,725 51,122 55,862
30 West Sulawesi 22,680 31,079 40,033 50,366 60,999 71,459
31 Maluku 31,182 39,490 48,915 58,509 68,571 78,937
32 North Maluku 24,539 28,181 35,637 41,850 46,807 54,343
33 West Papua 19,305 24,481 30,921 38,567 44,942 54,203
34 Papua 58,375 68,842 79,977 92,903 105,818 112,824
Indonesia 5,739,732 7,057,933 8,331,558 9,779,549 11,189,980 12,497,915

In Fig. 2, it is known that the prevalence of Diabetes is projected at 16.09% in 2045 without intervention and will be lower to 15.68%, or reduced by 5.54%, if the intervention is carried out to increase the coverage of villages with Posbindu and SPM of Diabetes services to 100%. The prevalence will be even lower to 9.22% or reduced by 42.69% if the program intervention is added by preventing the rise of the risk factors (overweight, obesity, central obesity, and consumption of fatty foods).

Figure 2.

Figure 2

Projection of diabetes prevalence in Indonesia in three scenarios, 2020–2045.

The cases of Diabetes in 2045 is estimated at 40.7 million without intervention. If with the intervention of increasing the program of village with Posbindu and SPM of Diabetes services, the cases are reduced to 39.6 million cases. The cases are even lower if the program is added to halt the increase of risk factors (overweight, obesity, central obesity, consumption of fatty foods), then cases become 23.2 million (Fig. 3).

Figure 3.

Figure 3

Projection of diabetes cases in Indonesia in three scenarios, 2020–2045.

Projection of mortality due to diabetes

The number of deaths due to Diabetes in Indonesia and each province is estimated to increase quite high in 2020–2045. Nationally, the number of deaths due to Diabetes increased from 433,752 in 2020 to 944,468 in 2045 (Fig. 4, Table 5). Stroke deaths among Diabetes cases increased from 52,397 in 2020 to 114,092 in 2045. Deaths from IHD among Diabetes cases increased from 35,351 in 2020 to 76,974 in 2045. Meanwhile, deaths from chronic kidney disease among Diabetes cases rose from 29,061 in 2020 to 63,279 in 2045. Additionally, deaths due to Diabetic Ketoacidosis (DKA) among Diabetes cases rose from 162,382 to 353,576. The number of deaths from Diabetes and its complications increased by 117% over 25 years or an average of 4.7% per year (Tables 6, 7, 8 and 9).

Figure 4.

Figure 4

Projection of number of deaths due to diabetes in Indonesia, 2045.

Table 5.

Projection of deaths due to diabetes in Indonesia, 2020–2045.

No Province Projection of number of deaths due to diabetes
2020 2025 2030 2035 2040 2045
1 Aceh 7459 9654 12,056 14,740 17,432 20,271
2 North Sumatera 21,892 27,548 33,228 39,174 45,603 50,375
3 West Sumatera 7826 9998 12,346 15,143 17,766 20,442
4 Riau 9812 13,394 17,400 21,586 25,886 30,705
5 Jambi 4234 5402 6703 7980 9468 11,145
6 South Sumatera 10,727 14,320 18,323 22,674 27,404 31,999
7 Bengkulu 2489 3207 3801 4526 5330 6365
8 Lampung 9824 12,739 15,879 18,968 22,282 24,875
9 Bangka Belitung 2468 3048 3729 4416 5035 5773
10 Riau Island 3765 5061 6577 8406 10,517 12,880
11 Jakarta 27,157 31,630 36,612 40,528 44,840 48,574
12 West Java 81,819 98,538 114,929 132,433 149,794 166,357
13 Central Java 56,262 68,093 78,833 90,543 100,233 110,091
14 Yogyakarta 9,129 11,064 13,181 15,490 18,355 21,270
15 East Java 73,869 87,434 99,426 110,660 122,665 134,198
16 Banten 21,549 25,700 31,915 36,617 42,134 47,323
17 Bali 8244 10,544 12,692 15,197 17,297 20,154
18 West Nusa Tenggara 5810 7100 9260 11,106 13,566 15,637
19 East Nusa Tenggara 3503 4959 6364 7697 9543 11,001
20 West Kalimantan 6386 8260 9786 12,012 14,457 16,415
21 Central Kalimantan 3470 4309 5239 6264 7232 8092
22 South Kalimantan 6488 8080 9713 11,469 13,221 14,840
23 East Kalimantan 7938 9469 11,189 13,128 14,900 16,734
24 North Kalimantan 1733 1999 2322 2606 2865 3202
25 North Sulawesi 4745 5506 6227 6720 7538 8111
26 Central Sulawesi 4780 5818 6644 7806 8959 10,328
27 South Sulawesi 13,467 17,486 21,021 25,491 29,174 33,184
28 Southeast Sulawesi 3679 4694 5813 7175 8566 9973
29 Gorontalo 2198 2683 2943 3455 3863 4221
30 West Sulawesi 1714 2349 3025 3806 4610 5400
31 Maluku 2356 2984 3697 4422 5182 5965
32 North Maluku 1854 2130 2693 3163 3537 4107
33 West Papua 1459 1850 2337 2915 3396 4096
34 Papua 4411 5202 6044 7021 7997 8526
Indonesia 433,752 533,368 629,616 739,041 845,627 944,468

Table 6.

Projection of deaths due to stroke among Diabetes cases in Indonesia, 2020–2045.

No Province Projection of number of deaths
2020 2025 2030 2035 2040 2045
1 Aceh 901 1166 1456 1781 2106 2449
2 North Sumatera 2645 3328 4014 4732 5509 6085
3 West Sumatera 945 1208 1491 1829 2146 2469
4 Riau 1185 1618 2102 2608 3127 3709
5 Jambi 511 653 810 964 1144 1346
6 South Sumatera 1296 1730 2213 2739 3310 3865
7 Bengkulu 301 387 459 547 644 769
8 Lampung 1187 1539 1918 2291 2692 3005
9 Bangka Belitung 298 368 450 533 608 697
10 Riau Island 455 611 795 1016 1271 1556
11 Jakarta 3281 3821 4423 4896 5417 5868
12 West Java 9884 11,903 13,883 15,998 18,095 20,096
13 Central Java 6796 8226 9523 10,938 12,108 13,299
14 Yogyakarta 1103 1337 1592 1871 2217 2569
15 East Java 8923 10,562 12,011 13,368 14,818 16,211
16 Banten 2603 3,105 3855 4423 5090 5717
17 Bali 996 1,274 1533 1836 2089 2435
18 West Nusa Tenggara 702 858 1119 1342 1639 1889
19 East Nusa Tenggara 423 599 769 930 1153 1329
20 West Kalimantan 771 998 1182 1451 1746 1983
21 Central Kalimantan 419 521 633 757 874 978
22 South Kalimantan 784 976 1173 1385 1597 1793
23 East Kalimantan 959 1144 1352 1586 1800 2021
24 North Kalimantan 209 242 281 315 346 387
25 North Sulawesi 573 665 752 812 911 980
26 Central Sulawesi 577 703 803 943 1082 1248
27 South Sulawesi 1627 2112 2539 3079 3524 4009
28 Southeast Sulawesi 444 567 702 867 1035 1205
29 Gorontalo 266 324 355 417 467 510
30 West Sulawesi 207 284 365 460 557 652
31 Maluku 285 360 447 534 626 721
32 North Maluku 224 257 325 382 427 496
33 West Papua 176 223 282 352 410 495
34 Papua 533 628 730 848 966 1030
Indonesia 52,397 64,431 76,058 89,276 102,152 114,092

Table 7.

Projection of deaths due to ischemic heart disease among diabetes cases in Indonesia, 2020–2045.

No Province Projection of number of deaths
2020 2025 2030 2035 2040 2045
1 Aceh 608 787 983 1201 1421 1652
2 North Sumatera 1784 2245 2708 3193 3717 4106
3 West Sumatera 638 815 1006 1234 1448 1666
4 Riau 800 1,092 1418 1759 2110 2502
5 Jambi 345 440 546 650 772 908
6 South Sumatera 874 1,167 1493 1848 2233 2608
7 Bengkulu 203 261 310 369 434 519
8 Lampung 801 1,038 1294 1546 1816 2027
9 Bangka Belitung Island 201 248 304 360 410 470
10 Riau Island 307 412 536 685 857 1050
11 Jakarta 2213 2578 2984 3303 3654 3959
12 West Java 6668 8031 9367 10,793 12,208 13,558
13 Central Java 4585 5550 6425 7379 8169 8972
14 Yogyakarta 744 902 1074 1262 1496 1734
15 East Java 6020 7126 8103 9019 9997 10,937
16 Banten 1756 2095 2601 2984 3434 3857
17 Bali 672 859 1034 1239 1410 1643
18 West Nusa Tenggara 474 579 755 905 1106 1274
19 East Nusa Tenggara 285 404 519 627 778 897
20 West Kalimantan 520 673 798 979 1178 1338
21 Central Kalimantan 283 351 427 511 589 660
22 South Kalimantan 529 659 792 935 1078 1209
23 East Kalimantan 647 772 912 1070 1214 1364
24 North Kalimantan 141 163 189 212 234 261
25 North Sulawesi 387 449 508 548 614 661
26 Central Sulawesi 390 474 542 636 730 842
27 South Sulawesi 1098 1425 1713 2078 2378 2704
28 Southeast Sulawesi 300 383 474 585 698 813
29 Gorontalo 179 219 240 282 315 344
30 West Sulawesi 140 191 247 310 376 440
31 Maluku 192 243 301 360 422 486
32 North Maluku 151 174 219 258 288 335
33 West Papua 119 151 190 238 277 334
34 Papua 360 424 493 572 652 695
Indonesia 35,351 43,470 51,314 60,232 68,919 76,974

Table 8.

Projection of deaths due to chronic kidney disease among diabetes cases in Indonesia, 2020–2045.

No Province Projection of number of deaths
2020 2025 2030 2035 2040 2045
1 Aceh 500 647 808 988 1168 1358
2 North Sumatera 1467 1846 2226 2625 3055 3375
3 West Sumatera 524 670 827 1015 1190 1370
4 Riau 657 897 1166 1446 1734 2057
5 Jambi 284 362 449 535 634 747
6 South Sumatera 719 959 1228 1519 1836 2144
7 Bengkulu 167 215 255 303 357 426
8 Lampung 658 853 1064 1271 1493 1667
9 Bangka Belitung Island 165 204 250 296 337 387
10 Riau Island 252 339 441 563 705 863
11 Jakarta 1819 2119 2453 2715 3004 3254
12 West Java 5482 6602 7700 8873 10,036 11,146
13 Central Java 3770 4562 5282 6066 6716 7376
14 Yogyakarta 612 741 883 1038 1230 1425
15 East Java 4949 5858 6662 7414 8219 8991
16 Banten 1444 1722 2138 2453 2823 3171
17 Bali 552 706 850 1018 1159 1350
18 West Nusa Tenggara 389 476 620 744 909 1048
19 East Nusa Tenggara 235 332 426 516 639 737
20 West Kalimantan 428 553 656 805 969 1100
21 Central Kalimantan 232 289 351 420 485 542
22 South Kalimantan 435 541 651 768 886 994
23 East Kalimantan 532 634 750 880 998 1121
24 North Kalimantan 116 134 156 175 192 215
25 North Sulawesi 318 369 417 450 505 543
26 Central Sulawesi 320 390 445 523 600 692
27 South Sulawesi 902 1172 1408 1708 1955 2223
28 Southeast Sulawesi 247 314 389 481 574 668
29 Gorontalo 147 180 197 232 259 283
30 West Sulawesi 115 157 203 255 309 362
31 Maluku 158 200 248 296 347 400
32 North Maluku 124 143 180 212 237 275
33 West Papua 98 124 157 195 228 274
34 Papua 296 349 405 470 536 571
Indonesia 29,061 35,736 42,184 49,516 56,657 63,279

Table 9.

Projection of deaths due to diabetic ketoacidosis among diabetes cases in Indonesia, 2020–2045.

No Province Projection of number of deaths
2020 2025 2030 2035 2040 2045
1 Aceh 2792 3614 4513 5518 6526 7589
2 North Sumatera 8196 10,313 12,440 14,665 17,072 18,859
3 West Sumatera 2930 3743 4622 5669 6651 7653
4 Riau 3673 5014 6514 8081 9691 11,495
5 Jambi 1585 2022 2509 2987 3545 4172
6 South Sumatera 4016 5361 6860 8488 10,259 11,979
7 Bengkulu 932 1201 1423 1694 1995 2383
8 Lampung 3678 4769 5945 7101 8342 9312
9 Bangka Belitung Island 924 1141 1396 1653 1885 2161
10 Riau Island 1410 1895 2462 3147 3937 4822
11 Jakarta 10,166 11,841 13,706 15,172 16,787 18,184
12 West Java 30,630 36,889 43,026 49,578 56,078 62,278
13 Central Java 21,063 25,492 29,512 33,896 37,524 41,214
14 Yogyakarta 3418 4142 4935 5799 6872 7963
15 East Java 27,654 32,732 37,222 41,427 45,922 50,239
16 Banten 8067 9621 11,948 13,708 15,774 17,716
17 Bali 3086 3947 4751 5689 6475 7545
18 West Nusa Tenggara 2175 2658 3467 4158 5079 5854
19 East Nusa Tenggara 1311 1857 2382 2882 3573 4119
20 West Kalimantan 2391 3092 3664 4497 5412 6145
21 Central Kalimantan 1299 1613 1961 2345 2707 3029
22 South Kalimantan 2429 3025 3636 4294 4950 5555
23 East Kalimantan 2972 3545 4,189 4915 5578 6265
24 North Kalimantan 649 748 869 975 1073 1199
25 North Sulawesi 1776 2061 2331 2516 2822 3037
26 Central Sulawesi 1790 2178 2487 2922 3354 3866
27 South Sulawesi 5042 6546 7870 9543 10,922 12,423
28 Southeast Sulawesi 1377 1757 2176 2686 3207 3733
29 Gorontalo 823 1004 1102 1294 1446 1580
30 West Sulawesi 642 879 1133 1425 1726 2022
31 Maluku 882 1117 1384 1655 1940 2233
32 North Maluku 694 797 1008 1184 1324 1537
33 West Papua 546 693 875 1091 1271 1533
34 Papua 1651 1948 2263 2628 2994 3192
Indonesia 162,382 199,675 235,707 276,671 316,574 353,576

At the provincial level, deaths due to Diabetes and its three complications in 2045 are highest in West Java province with 166,357 deaths due to Diabetes, 3,202 deaths from stroke among Diabetes, 13,558 deaths from IHD among Diabetes, and 11,146 deaths from CKD among Diabetes. The lowest mortality was in North Kalimantan province with 3,202 deaths due to Diabetes, 387 deaths from stroke among Diabetes, 261 deaths from IHD among Diabetes, and 215 deaths from CKD among Diabetes Tables 6, 7, 8 and 9).

Figure 5 shows that the number of deaths due to Diabetes in 2045 is estimated at 944,468 if without intervention and lower to 919,206 (reduced by 2.67%) if program improvement interventions are carried out and to 537,190 (reduced by 43.12%) if program improvement is added with controlling of the risk factors increase.

Figure 5.

Figure 5

Projection of deaths due to diabetes in three scenarios in Indonesia, 2020–2045.

Discussion

The result of the study shows that the prevalence of Diabetes in Indonesia increased from 9.19% in 2020 (18.69 million cases) to 16.09% in 2045 (40.7 million cases) or an increase of 75.1% over 25 years, or an average of 3% per year. The province with the highest prevalence in 2045 is Jakarta (23.11%) and the lowest is East Nusa Tenggara province (8.91%). The largest number of cases in 2045 is in West Java Province (7,170,569 cases) and the lowest is in North Kalimantan Province (138,038 cases). The results of this study indicate a large increase in the prevalence and number of Diabetes cases in Indonesia, if adequate prevention and control of the NCDs risk factors programs are not carried out. Jakarta Province is an urban area which have higher Diabetes risk factors so that the prevalence is the highest. NTT Province is a rural province with a lower risk of Diabetes, so the prevalence is the lowest. The size of cases corresponds to the magnitude of the prevalence and the number of adult populations. The number of Diabetes cases is according to the prevalence and number of people aged 15 years and over, so provinces with large populations tend to have a larger number of Diabetes cases. West Java Province is the largest province in Indonesia so that the number of cases is the largest, while North Kalimantan province is the province with the smallest population so that the number of Diabetes cases is also the lowest.

The increase in the prevalence of Diabetes in Indonesia is almost the same as the results of other studies. In Indonesia, Nuryati’s research in 201227 shows that the prevalence diabetes among adults in Indonesia 8.04%. This study was a cross sectional study using secondary data from Basic Health Research 2007 with respondents above 18 years using oral glucose tolerance test. Nuryati’s study used the same as this study from Basic Health Research but with different period (2007 and 2018 data) so the prevalence was quite same. But, the projection from this study is higher that projection of Nurhayati16 that by 2020 the prevalence was 8.71% in Indonesia and 9.49% in 2024. Nurhayati’s study used a literature review based on Institute of Health Metric and Evaluation (IHME) data which was based on relative risk modelling using regression analysis. This projection is different from this study which used not only risk factors but also Diabetes programs. It indicates that the programs influence the burden of diabetes in Indonesia.

In Thailand, Mahikul et al.28 reported that Diabetes prevalence is predicted to increase from 6.5% in 2015 to 10.69% in 2035 or an increase of 64.4% over 20 years or 3.2% per year. According to data from the Institute of Health Metric and Evaluation, the prevalence of Diabetes in Indonesia in 2019 is estimated at 3.98% of the entire population or 10.33 million cases1. In China, research of Pan et al.29 in a systematic review 1987–2007 reported that the prevalence of Diabetes in China in 2009 was 3.9% (urban 5.2%, rural 2.9%) and is predicted to increase to 5.4% (urban 6.9%, rural 3.8%) in 2016, or an increase of 38.4% over 7 years or an annual increase of 4.6%. Meanwhile, the number of Diabetes cases is projected to increase from 53.1 million cases in 2009 to 76.1 million cases in 2016. In Sweden, Andersson et al.30 reported that the prevalence of Diabetes increased from 5.8% in 2007 to 6.8% in 2013 (2013) and will rise to 10.4% in 2050 or an increase of 79.3% over 1.8% per year. The number of cases is predicted to increase to 940,000 and every 1% increase in annual incidence will result in an increase of 12.6% prevalence and 1,136 000 cases.

In the United States by Boyle et al.19 where if Diabetes mortality is high, then Diabetes prevalence increases from 14% in 2010 to 21% in 2050 (increase of 50% or 1.25% per year) and to 33% in 2050 (increase of 135%) or 3.3% per year) for 40 years if mortality is low. Rowley et al.18 in the US The prevalence of Diabetes will increase by 54% to more than 54.9 million US population between 2015 and 2030. Diabetes—related annual deaths will rise by 38% to 385,800. Another study by Mainous et al.31 in the United States, projections of Diabetes burden based on individual risk prevalence show that the total burden of Diabetes is estimated at 11.5% (25.4 million) in 2011, 13.5% (32.6 million) in 2021, and 14.5% (37.7 million) in 2031 or an increase of 26% over 20 years with an average increase of 1.3% per year. Wild et al.32 projected that diabetes prevalence is estimated at 2.8% in 2000 and increases to 4.4% by 2030 worldwide, or an increase of 57.1% from the prevalence over 30 years, with an average of 1.9% increase per year. The number of people with diabetes in the world is expected to increase from 171 million cases in 2000 to 366 million cases in 2030.

Based on the scenarios, the results of this study show that the prevalence of Diabetes by 2045 was 16.09% and can be reduced to 15.68%, or reduced by 5.54%, if program intervention namely increase of the coverage of villages with Posbindu and SPM of Diabetes services to 100%. This figure can be lowered again to 9.22% or reduced by 42.69% if the program intervention is added with prevention of risk factors (overweight, obesity, central obesity and consumption of fatty foods). These results show that existing program interventions (Posbindu village and SPM of Diabetes services play a role in reducing the prevalence of Diabetes but not so large. The reduction will be much greater if prevention of the main risk factors for Diabetes are overweight, obesity, central obesity, and consumption of fatty foods.

To reduce Diabetes cases, efforts are needed to control risk factors that positively affect Diabetes projections, namely overweight, obesity, central obesity, and consumption of fatty foods. These control efforts are carried out through increasing education, physical activity, and efforts to change the pattern of consumption of fatty foods into healthy foods (enough fruits and vegetables). Efforts to halt the prevalence rate of these four risk factors can be made through a combination of physical activity and a healthy diet. Intervention targets need to be more specific to at-risk populations. Research by Gregg et al.33 in the United States, shows that by 2030 it is projected that 4.6 million incidences and 3.6 million cases of Diabetes prevalence or reducing the prevalence rate by 14% can be prevented by a combination of prevention strategies. This prevention strategy is developed with structured lifestyle interventions for high-risk (pre-diabetic), moderate-risk, and general populations.

The Ministry of Health of Indonesia needs to make policies and programs to prevent risk factors. The program can be through educational efforts through the Healthy Living Community Movement (GERMAS) and healthy behavior in the community. It is necessary to increase 100% Village with Posbindu. In addition, the achievement of Diabetes health service SPM becomes 100% every year. National Planning Bureau needs to include efforts to control Diabetes risk factors, especially overweight, obesity, central obesity, and unhealthy consumption patterns in health program plans in Indonesia and provide sufficient budget related to Posbindu and Diabetes health service SPM.

The results showed that the projected number of deaths due to Diabetes in Indonesia increased from 433,752 deaths in 2020 to 944,468 in 2045. Stroke deaths in Diabetes increased from 52,397 in 2020 to 114,092 in 2045. Deaths from IHD in Diabetes increased from 35,351 in 2020 to 76,974 in 2045. Meanwhile, deaths from chronic kidney disease in Diabetes increased from 29,061 in 2020 to 63,279 in 2045. The number of deaths from Diabetes and its complications increased by 117% over 25 years or an average of 4.7% per year.

These results indicate that Diabetes is one of the highest causes of death in Indonesia. Based on data from the Institute of Health Metric and Evaluation, deaths from Diabetes in Indonesia in 2019 amounted to 40.98 per 100,000 population or 106,333 deaths. It has the largest increase of all other causes of death for 128.7% from 19901. Meanwhile, based on data from the 2015 Sample Registration System, Diabetes is the third highest cause of death in Indonesia after stroke and ischemic heart disease with a proportion of 7.8%34, an increase from 5.7% in 20072.

In Singapore, research by Tan et al.17 shows that Diabetes complications in 2050 in the form of acute myocardial infarction will increase from 9300 deaths (2019) to 16,400 (2050), the number of stroke increase from 7300 to 12,800, the number of end-stage kidney disease from 1700 to 2700. This number increased by an average of 76.3% over 30 years. In Thailand, Mahikul et al.28 in their study predicted death in undiagnosed Diabetes 10 times greater than undiagnosed Diabetes. The positive screening rate decreased mortality in women aged 15–34 years at 10 years. This indicates the importance of blood sugar screening so that people can be aware of the dangers of diabetes and can make prevention and control efforts independently. Research by Foreman et al.35 shows that deaths from Diabetes in the world amounted to 1,437,000 in 2016 to 2,971,000 in 2040, or an increase of 106.7% over 24 years, with an average increase of 4.4% per year. Deaths from Diabetes -related kidney disease in the world 500,000 in 2016 to 1380 in 2040. Stroke deaths in the world were 5,528,000 in 2016 to 5973 in 2040. The number of ischemic heart disease deaths worldwide was 9,480,000 in 2016 to 10,872,000 in 2040.

Deaths from Diabetes and its complications need to be suppressed with appropriate primary, secondary, and tertiary prevention. Ministry of Health to improve such prevention adequately. On primary prevention to prevent complications in people with diabetes through diet modification and a healthy lifestyle. In secondary prevention, treatment of Diabetes and its complications needs to be provided to all patients using the latest technology. Increased achievement of SPM of Diabetes Health services. In tertiary prevention, rehabilitation for advanced cases such as diabetic foot care needs to be expanded, including home care services.

To reduce the fatality of diabetes due to its complications such as Stroke, Ischemic heart disease, Chronic kidney disease and immediate fatality due to Diabetic Ketoacidosis, interventions of the disease should be enhanced across the regions in Indonesia. Chronic disease management program (Prolanis), number of primary health care facilities providing optimal diabetes services (NCD integrated services), and the participation of healthy life movement (GERMAS) should be strengthened. Meanwhile, achievement of blood glucose targets under Prolanis and the percentage of diabetic patients receiving scheduled screenings and counselling with specialists should be increased.

This study has several limitations in terms of quality and representation of research data. This is due to inconsistent data, missing data, and program coverage data exceeding 100%. For inconsistent data, projections use their mean and standard deviation. For data that exceeds the target of 100%, the data is fulfilled to a maximum of 100%. There are 3.3–34.6% missing data that can reduce data quality in making projections. For these circumstances, the data is filled in using the average province of the district so that the data does not deviate from the actual condition.

Data representation for village with Posbindu, Pandu, and SPM of Diabetes services, and SPM of screening are routine data that is inputted by district government which tends to overestimate, because there is no individual data. However, this data is an official release from the Ministry of Health so it can still be used. The data analyzed in this study is aggregate data at the district level (205 districts/cities out of 514 districts/cities) to estimate the burden of Diabetes at the district, provincial, and national levels. This can cause actual projections to vary more than the results of this study because not all district data are analyzed in the preparation of the model. However, with a provincial MAPE value of 13% that is good at making projections at the provincial level and MAPE at the district / city level, the projection is still quite feasible to estimate conditions in the district/city.

Conclusion

Diabetes morbidity and mortality in Indonesia is projected to rise significantly in Indonesia from 2020 to 2045. The prevalence increases 75.1% over 25 years, with an average of 3% from prevalence per year. The number of deaths from Diabetes and its complications increased by 117% over 25 years or an average of 4.7% per year. Morbidity and mortality can be reduced by intervention of several programs (Village with NCD Post/Posbindu, standard service of diabetes) and risk factors control (overweight, obesity, central obesity, and fatty food consumption). It is recommended to Ministry of Health and health policy makers to use this study result as source of planning and evaluation of diabetes prevention and control program. I need to strengthen the program of risk factor monitoring trough Posbindu, achieve target of minimum standard services of diabetes, and increase healthy lifestyle including physical activity and healthy diet to control overweight and obesity.

Acknowledgements

The authors thank the Head of Policy and Development Body, Ministry of Health, Director of Non-Communicable Disease Prevention and Control, and Director of national Health Insurance (BPJS) who provided data and support this research.

Abbreviations

DM

Diabetes Mellitus

MAPE

Absolute Mean Percentage Error

NCD

Non Communicable Disease

Pandu

Pelayanan Terpadu (NCD integrated services at Primary Health Center)

Posbindu

Pos Pembinaan Terpadu (NCD integrated post at community)

Prolanis

Program pelayanan penyakit kronis (Chronic disease management)

SPM

Standar Pelayanan Minimal (Minimum Standard Services)

Author contributions

M.W. and A.A. developed the concept and wrote main manuscript. M.W. conducted data acquisition. Data analyze was performed by M.W.B., S.K., and D.K. Data interpretation and result writing were conducted by M.W., A.A.B., S.K., E.R., M.P., S.R., M.N., A.N., and D.K. Discussion writing was performed by M.W., A.A.B., S.K., E.R., M.P., S.R., M.N., and A.N. All authors reviewed and agreed on the final manuscript.

Funding

The research is funded by Universitas Indonesia which is stated in Grant Agreement No NKB-1130/UN2.RST/HKP.05.00/2022.

Data availability

Data of the research is available and can be shared on request to Anhari Achadi at aachadi@gmail.com.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.IHME. Burden of Disease, 2019. Available at https://vizhub.healthdata.org/gbd-compare/ (2020).
  • 2.Kemenkes RI. Report on result of national basic health research (Riskesdas) 2007. Available at https://repository.badankebijakan.kemkes.go.id/id/eprint/4386/1/Report%20on%20Result%20of%20National%20Basic%20Health%20Research%202007.pdf (2008).
  • 3.Kemenkes RI. Laporan Nasional Riset Kesehatan Dasar (Riskesdas) 2013. Available at https://repository.badankebijakan.kemkes.go.id/id/eprint/4467/1/Laporan_riskesdas_2013_final.pdf (2013).
  • 4.Kemenkes RI. Laporan Nasional Riset Kesehatan Dasar (Riskesdas) 2018. Available at https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan%20Riskesdas%202018%20Nasional.pdf (2019).
  • 5.WHO . Summary Surveillance of Risk Factors for Noncommunicable Diseases The WHO STEPwise Approach. Geneva; 2001. [Google Scholar]
  • 6.Perkeni. Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia 2019. Available at https://pbperkeni.or.id/wp-content/uploads/2021/06/Pedoman-Pengelolaan-DM-Tipe-2-Dewasa-di-Indonesia-eBook-PDF.pdf (PB Perkeni, Jakarta, 2019).
  • 7.Kemenkes, R. I. Pedoman Umum Pencegahan dan Pengendalian DM Tipe 2 (Jakarta, 2016).
  • 8.Peters R, Ee N, Peters J, Beckett N, Booth A, Rockwood K, et al. Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: The implied potential for targeted risk reduction. Ther. Adv. Vaccines. 2018;9:259–261. doi: 10.1177/https. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhang H, Ni J, Yu C, Wu Y, Li J, Liu J, et al. Sex-based differences in diabetes prevalence and risk factors: A population-based cross-sectional study among low-income adults in China. Front. Endocrinol. (Lausanne) 2019;10:1–8. doi: 10.3389/fendo.2019.00658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Presiden RI . Peraturan Presiden RI Nomor 18 Tahun 2020 Tentang Rencana Pembangunan Jangka Menengah Nasional Tahun 2020 - 2024. Jakarta; 2020. [Google Scholar]
  • 11.Kemenkes RI . Peraturan Menteri Kesehatan Republik Indonesia Nomor 21 Tahun 2020 Tentang Rencana Strategis Kementerian Kesehatan Tahun 2020-2024. Jakarta; 2020. [Google Scholar]
  • 12.Kemenkes RI . Peraturan Menteri Kesehatan RI Nomor 4 Tahun 2019 tentang Standar Teknis Pemenurhan Mutu Pelayanan Dasar Pada Standar Pelayanan Minimal Bidang Kesehatan. Jakarta; 2019. [Google Scholar]
  • 13.Meng XH, Huang YX, Rao DP, Zhang Q, Liu Q. Comparison of three data mining models for predicting diabetes or prediabetes by risk factors. Kaohsiung J. Med. Sci. 2013;29:93–99. doi: 10.1016/j.kjms.2012.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nai-Arun N, Moungmai R. Comparison of classifiers for the risk of diabetes prediction. Procedia Comput. Sci. 2015;69:132–142. doi: 10.1016/j.procs.2015.10.014. [DOI] [Google Scholar]
  • 15.Tjokroprawiro A. Diabetes Mellitus di dalam-Masyarakat Indonesia. Bul. Penelit. Kesehat. 1993;1993:21. [Google Scholar]
  • 16.Nurhayati, H.-W. Projected number of people with diabetes Indonesia 2017–2024. Available at https://www.statista.com/statistics/1052625/indonesia-diabetes-projection/ (Statista, 2020).
  • 17.Tan KW, Dickens BSL, Cook AR. Projected burden of type 2 diabetes mellitus-related complications in Singapore until 2050: A Bayesian evidence synthesis. BMJ Open Diabetes Res. Care. 2020;2020:8. doi: 10.1136/bmjdrc-2019-000928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: Insights from yesterday, today, and future trends. Popul. Health Manag. 2017;20:6–12. doi: 10.1089/pop.2015.0181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 2010;8:1–12. doi: 10.1186/1478-7954-8-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hastono, S. P. Analisis Data. Depok: Fakultas Kesehatan Masyarakat Universitas Indonesia (Depok, 2006).
  • 21.Kleinbaum DG, et al. Applied Regression Analysis and Other Multivariable Methods. Duxbury Press; 1998. [Google Scholar]
  • 22.Purwata TE. High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy. J. Pain Res. 2011;4:169–175. doi: 10.2147/JPR.S21751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Halim A, Syumarti S, Rini M, Ratnaningsih N, Iskandar E, Sovani I, et al. Prevalence and associated factors of diabetic retinopathy in people with type 2 diabetes attending community based diabetic retinopathy screening in greater Bandung Indonesia. Int. J. Retin. 2022;5:1. doi: 10.35479/ijretina.2022.vol005.iss001.172. [DOI] [Google Scholar]
  • 24.Dewata DGUB, Novida H, Aryati A. Profile of diabetic ketoacidosis patients at regional public hospital Dr. Soetomo in 2017. J. Berk Epidemiol. 2020;8:301. doi: 10.20473/jbe.v8i32020.301-309. [DOI] [Google Scholar]
  • 25.Siregar NN, Soewondo P, Subekti I, Muhadi M. Seventy-two hour mortality prediction model in patients with diabetic ketoacidosis: A retrospective cohort study. J. ASEAN Fed. Endocr. Soc. 2018;33:124–129. doi: 10.15605/jafes.033.02.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sterman JD. Business Dinamics: Systems Thinking and Modeling for a Complex World. New York: Irwin McGraw-Hill; 2004. [Google Scholar]
  • 27.Nuryati E. Faktor prediksi diabetes melitus tidak terdiagnosis ada usia dewasa di Indonesia Tahun 2011. J. Ilm Kesehat. 2012;2012:1. doi: 10.35952/jik.v1i1.106. [DOI] [Google Scholar]
  • 28.Mahikul W, White LJ, Poovorawan K, Soonthornworasiri N, Sukontamarn P, Chanthavilay P, et al. A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand. Int. J. Environ. Res. Public Health. 2019;16:1–11. doi: 10.3390/ijerph16122207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pan C, Shang S, Kirch W, Thoenes M. Burden of diabetes in the adult Chinese population: A systematic literature review and future projections. Int. J. Gen. Med. 2010;3:173–179. doi: 10.2147/ijgm.s6343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Andersson T, Ahlbom A, Carlsson S. Diabetes prevalence in Sweden at present and projections for year 2050. PLoS One. 2015;10:1–11. doi: 10.1371/journal.pone.0143084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mainous AG, Baker R, Koopman RJ, Saxena S, Diaz VA, Everett CJ, et al. Impact of the population at risk of diabetes on projections of diabetes burden in the United States: An epidemic on the way. Diabetologia. 2007;50:934–940. doi: 10.1007/s00125-006-0528-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wild SH, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:2568–2569. doi: 10.2337/diacare.27.10.2568. [DOI] [PubMed] [Google Scholar]
  • 33.Gregg EW, Boyle JP, Thompson TJ, Barker LE, Albright AL, Williamson DF. Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010–2030. Popul. Health Metr. 2013;11:1–9. doi: 10.1186/1478-7954-11-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kemenkes RI. Indonesia: Sample registration system 2014. Jakarta: Lembaga Penerbitan Balitbangkes; 2015. [Google Scholar]
  • 35.Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392:2052–2090. doi: 10.1016/S0140-6736(18)31694-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data of the research is available and can be shared on request to Anhari Achadi at aachadi@gmail.com.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES